Target
RAF proto-oncogene serine/threonine-protein kinase
Ligand
BDBM50237792
Substrate
n/a
Meas. Tech.
ChEMBL_1663046 (CHEMBL4012727)
EC50
200±n/a nM
Citation
 Nishiguchi, GARico, ATanner, HAversa, RJTaft, BRSubramanian, SSetti, LBurger, MTWan, LTamez, VSmith, ALou, YBarsanti, PAAppleton, BAMamo, MTandeske, LDix, ITellew, JEHuang, SMathews Griner, LACooke, VGVan Abbema, AMerritt, HMa, SGampa, KFeng, FYuan, JWang, YHaling, JRVaziri, SHekmat-Nejad, MJansen, JMPolyakov, VZang, RSethuraman, VAmiri, PSingh, MLees, EShao, WStuart, DDDillon, MPRamurthy, S Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers. J Med Chem 60:4869-4881 (2017) [PubMed]  Article 
Target
Name:
RAF proto-oncogene serine/threonine-protein kinase
Synonyms:
C-Raf Protein Kinase | Proto-oncogene c-RAF (RAF1) | RAF proto-oncogene serine/threonine-protein kinase (C-Raf) | Raf-1 | Serine/threonine-protein kinase RAF | Serine/threonine-protein kinase C-Raf | cRaf | RAF1_HUMAN | RAF1 | RAF
Type:
Serine/threonine-protein kinase
Mol. Mass.:
73082.52
Organism:
Human
Description:
P04049
Residue:
648
Sequence:
MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF
  
Inhibitor
Name:
BDBM50237792
Synonyms:
CHEMBL4081025
Type:
Small organic molecule
Emp. Form.:
C26H30N4O2
Mol. Mass.:
430.24
SMILES:
Cc1ccc(cc1-c1cc(ncn1)N1CCOCC1)C(=O)Nc1cccc(c1)C(C)(C)C
Structure:
Search PDB for entries with ligand similarity: